Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies.

Collins, Christopher E; Cortes-Hernández, Josefina; Garcia, Mercedes A; von Kempis, Johannes; Schwarting, Andreas; Touma, Zahi; Kurtinecz, Milena; Gairy, Kerry

Collins, Christopher E; Cortes-Hernández, Josefina; Garcia, Mercedes A; von Kempis, Johannes; Schwarting, Andreas; Touma, Zahi; Kurtinecz, Milena; Gairy, Kerry.

Afiliação

Collins CE; MedStar Washington Hospital Center, Washington, DC, USA.
Cortes-Hernández J; Vall d'Hebron Hospital, Barcelona, Spain.
Garcia MA; HIGA San Martín, La Plata, Argentina.
von Kempis J; Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Schwarting A; University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Touma Z; Toronto Western Hospital, University of Toronto Lupus Clinic, Toronto, ON, Canada.
Kurtinecz M; GSK, Collegeville, PA, USA.
Gairy K; GlaxoSmithKline, London, UK. kerry.x.gairy@gsk.com.

Rheumatol Ther ; 7(4): 949-965, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33206344

Palavras-chave

Belimumab; Glucocorticosteroid sparing; Real-world effectiveness; Real-world experience; SLE; Systemic lupus erythematosus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatol Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google